Malvinder Mohan Singh is an Indian businessman with Ranbaxy and Religare business. He is a former chairman and CEO of Ranbaxy Laboratories, an Indian pharmaceutical company that he sold to Japanese drugmaker Daiichi Sankyo, who resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit. Read More
The Supreme Court on Friday held former Ranbaxy promoters, Malvinder and Shivinder Singh, guilty of contempt for violating the order directing the duo to not divest their shares in Fortis Healthcare Ltd. ...
The Enforcement Directorate (ED) on Thursday said that it has arrested former Relkigare Health Enterprises Ltd promoters Malvinder Singh and Sunil Godhwani in connection with its probe into a money laundering case. ...
Rs 1,260 crore has been diverted to Malvinder Singh's firm RHC Holdings Pvt Ltd in order to square off liabilities, the Economic Offences Wing (EOW) probing the Religare Fraud Case told a Delhi Court. ...
A Delhi court on Friday sent Malvinder Singh, Shivinder Singh, Kavi Arora, Sunil Godhwani and Sunil Saxena to four days of police remand in the Religare fraud case. ...
The economic offences wing (EOW) of Delhi police have detained former Ranbaxy chief executive officer (CEO) Malvinder Singh from Punjab's Ludhiana based on the complaint given by Manpreet Singh Suri of Religare Finvest Ltd (RFL) in an alleged fraud c ...
Religare Enterprises Ltd (REL), a financial services group, has entered into a share purchase agreement (SPA) for sale of its NBFC business Religare Finvest to TCG Advisory Services for Rs 330 crore. ...
